Mestag Therapeutics Ltd
Research and experimental development on biotechnology · Saffron Walden
ActiveUnited KingdomIncorporated 2020Private Limited Company
Ownership evidence
Reported ownership and control rights in this business, with source dates.
Reported ownership & control
1 without an end date · 1 ceasedJohnson & JohnsonCorporate
Shares: over 25%, up to 50%
Notified 2024-10-14 · No cessation recorded
Source record 237178695Show 1 ceased record
Sv7 (Imf) Gp LlpCorporate
Shares: over 75%, up to 100%Voting rights: over 75%, up to 100%Right to appoint or remove directors
Notified 2020-02-17 · Ceased 2021-07-16
Source record 235606940People behind the business
Current appointments and the wider business interests of each person.
Appointments
8 current · 8 historicalMV
Martinus Adrianus Van OschCurrent director
Appointed 2025-06-02 · 1 yr · Director
DB
Diana BernsteinCurrent director
Appointed 2022-12-09 · 3 yrs · Director
TL
Ton LogtenbergCurrent director
Appointed 2022-02-08 · 4 yrs · Non-Executive Director
IR
Issi RozenCurrent director
Appointed 2021-07-16 · 5 yrs · Director
SH
Susan HillCurrent director
Appointed 2020-04-17 · 6 yrs · Director
Show 8 historical appointments
AB
Antoine Boulanger PietteResigned director
Resigned 2024-02-29 · 1 yr · Director
CD
Charles DunnResigned director
Resigned 2023-06-29 · 3 yrs · Director
SG
Shaan GandhiResigned director
Resigned 2021-07-16 · 1 yr · Director
JA
Juliette AudetResigned director
Resigned 2021-07-16 · 2 yrs · Director
KL
Kevin LeeResigned director
Resigned 2020-06-03 · Company Director
HA
Houman AshrafianResigned director
Resigned 2020-04-17 · 3 yrs · Director
JC
James CostineResigned director
Resigned 2020-02-17 · Director
JD
Jonathan DinesResigned director
Resigned 2020-02-17 · Director
Board profile
- People with appointments
- 8
- Directors assessed
- 8
- Median age
- 57
- Under 35
- 0
- 65 and over
- 2
- Disqualified match
- None active